MRC Human Genetics Unit, MRC Institute of Genetics and Molecular Medicine, the University of Edinburgh, Edinburgh EH4 2XU, United Kingdom.
Centre for Genomic and Experimental Medicine, MRC Institute of Genetics and Molecular Medicine, the University of Edinburgh, Edinburgh EH4 2XU, United Kingdom.
Genes Dev. 2020 Nov 1;34(21-22):1520-1533. doi: 10.1101/gad.340190.120. Epub 2020 Oct 15.
DNA replication is fundamental for cell proliferation in all organisms. Nonetheless, components of the replisome have been implicated in human disease, and here we report encoding the catalytic subunit of DNA primase as a novel disease gene. Using a variant classification agnostic approach, biallelic mutations in PRIM1 were identified in five individuals. PRIM1 protein levels were markedly reduced in patient cells, accompanied by replication fork asymmetry, increased interorigin distances, replication stress, and prolonged S-phase duration. Consequently, cell proliferation was markedly impaired, explaining the patients' extreme growth failure. Notably, phenotypic features distinct from those previously reported with DNA polymerase genes were evident, highlighting differing developmental requirements for this core replisome component that warrant future investigation.
DNA 复制是所有生物细胞增殖的基础。尽管如此,复制体的成分已被牵连到人类疾病中,在这里我们报道编码 DNA 引物酶的催化亚基的 PRIM1 作为一个新的疾病基因。使用一种无变异分类假设的方法,在五个人中发现了 PRIM1 的双等位基因突变。患者细胞中的 PRIM1 蛋白水平显著降低,伴随着复制叉不对称、起始原点之间距离增加、复制应激和 S 期持续时间延长。因此,细胞增殖受到明显抑制,这解释了患者的极度生长发育迟缓。值得注意的是,与先前报道的 DNA 聚合酶基因的表型特征明显不同,突出了该核心复制体成分在不同发育阶段的不同需求,这值得进一步研究。